DK2155228T3 - Polypeptidinhibitorer af HSP27-kinase og anvendelser herfor - Google Patents

Polypeptidinhibitorer af HSP27-kinase og anvendelser herfor

Info

Publication number
DK2155228T3
DK2155228T3 DK07836118.5T DK07836118T DK2155228T3 DK 2155228 T3 DK2155228 T3 DK 2155228T3 DK 07836118 T DK07836118 T DK 07836118T DK 2155228 T3 DK2155228 T3 DK 2155228T3
Authority
DK
Denmark
Prior art keywords
applications
kinase polypeptide
polypeptide inhibitors
hsp27 kinase
hsp27
Prior art date
Application number
DK07836118.5T
Other languages
English (en)
Inventor
Alyssa Panitch
Brandon Seal
Brian Ward
Original Assignee
Purdue Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Purdue Research Foundation filed Critical Purdue Research Foundation
Application granted granted Critical
Publication of DK2155228T3 publication Critical patent/DK2155228T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK07836118.5T 2007-01-10 2007-07-16 Polypeptidinhibitorer af HSP27-kinase og anvendelser herfor DK2155228T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US88013707P 2007-01-10 2007-01-10
PCT/US2007/016246 WO2008085191A1 (en) 2007-01-10 2007-07-16 Polypeptide inhibitors of hsp27 kinase and uses therefor

Publications (1)

Publication Number Publication Date
DK2155228T3 true DK2155228T3 (da) 2014-07-07

Family

ID=39608928

Family Applications (3)

Application Number Title Priority Date Filing Date
DK13001411.1T DK2617431T3 (da) 2007-01-10 2007-07-16 Polypeptidinhibitorer af HSP27-kinase og anvendelser derfor
DK07836118.5T DK2155228T3 (da) 2007-01-10 2007-07-16 Polypeptidinhibitorer af HSP27-kinase og anvendelser herfor
DK13001412.9T DK2606903T3 (da) 2007-01-10 2007-07-16 Polypeptidinhibitorer af HSP27-kinase og anvendelser herfor

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK13001411.1T DK2617431T3 (da) 2007-01-10 2007-07-16 Polypeptidinhibitorer af HSP27-kinase og anvendelser derfor

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK13001412.9T DK2606903T3 (da) 2007-01-10 2007-07-16 Polypeptidinhibitorer af HSP27-kinase og anvendelser herfor

Country Status (7)

Country Link
US (3) US8536303B2 (da)
EP (3) EP2155228B1 (da)
AU (1) AU2007342674B2 (da)
CA (2) CA2689296C (da)
DK (3) DK2617431T3 (da)
ES (3) ES2624196T3 (da)
WO (1) WO2008085191A1 (da)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2617431T3 (da) 2007-01-10 2017-07-10 Purdue Research Foundation Polypeptidinhibitorer af HSP27-kinase og anvendelser derfor
US20080293640A1 (en) * 2007-01-10 2008-11-27 Arizona Board of Regents, A body Corporate, of the State of Arizona, acting for and on behalf of Polypeptide inhibitors of HSP27 kinase and uses therefor
DK2185698T3 (da) 2007-08-07 2015-07-27 Purdue Research Foundation Kinaseinhibitorer og anvendelser deraf
ES2663662T3 (es) 2008-01-18 2018-04-16 President And Fellows Of Harvard College Métodos para detectar distintivos de enfermedades o afecciones en fluidos corporales
AU2009322865B2 (en) * 2008-10-20 2013-07-18 Moerae Matrix, Inc. Polypeptide for treating or preventing adhesions
AU2013202108B2 (en) * 2008-12-10 2015-12-24 Purdue Research Foundation Cell-permeant peptide-based inhibitor of kinases
KR101965255B1 (ko) 2008-12-10 2019-04-03 퍼듀 리서치 파운데이션 키나아제의 세포-침투성 펩티드-기초된 저해물질
WO2011017132A2 (en) * 2009-07-27 2011-02-10 Purdue Research, Foundation Mk2 inhibitor compositions and methods to enhance neurite outgrowth, neuroprotection, and nerve regeneration
EP2575855A4 (en) * 2010-05-24 2014-03-12 Moerae Matrix Inc METHOD FOR TREATING OR PREVENTING VASCULAR GRAFT BREAKAGE
SG10201505724SA (en) 2010-07-23 2015-09-29 Harvard College Methods of detecting diseases or conditions using phagocytic cells
US20130184178A1 (en) 2010-07-23 2013-07-18 President And Fellows Of Harvard College Methods of Detecting Autoimmune or Immune-Related Diseases or Conditions
WO2012012717A1 (en) 2010-07-23 2012-01-26 President And Fellows Of Harvard College Methods of detecting prenatal or pregnancy-related diseases or conditions
SG10201505723UA (en) 2010-07-23 2015-09-29 Harvard College Methods for detecting signatures of disease or conditions in bodily fluids
US9890200B2 (en) * 2011-04-12 2018-02-13 Moerae Matrix, Inc. Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition
ES2711670T3 (es) * 2011-04-12 2019-05-06 Moerae Matrix Inc Composiciones y métodos para la prevención o tratamiento de la fibrosis pulmonar
CA2747509C (en) 2011-05-12 2017-07-18 Oncogenex Technologies Inc. Treatment of pulmonary and pleural fibrosis using hsp27 inhibitors
WO2013134636A1 (en) 2012-03-09 2013-09-12 Purdue Research Foundation Compositions and methods for delivery of kinase inhibiting peptides
US20140072613A1 (en) * 2012-09-10 2014-03-13 Cynthia Lander Compositions and Methods for Treating Cutaneous Scarring
US11585814B2 (en) 2013-03-09 2023-02-21 Immunis.Ai, Inc. Methods of detecting prostate cancer
WO2014164366A1 (en) 2013-03-09 2014-10-09 Harry Stylli Methods of detecting cancer
US10336788B2 (en) * 2014-04-17 2019-07-02 Moerae Matrix, Inc. Inhibition of cardiac fibrosis in myocardial infarction
WO2016040843A1 (en) 2014-09-11 2016-03-17 Harry Stylli Methods of detecting prostate cancer
CN107106650A (zh) * 2014-11-17 2017-08-29 莫伊莱麦屈克斯公司 用于预防或治疗表征为异常的成纤维细胞增殖和细胞外基质沉积的疾病、状况或过程的组合物和方法
RU2017128077A (ru) 2015-01-08 2019-02-08 Мори Матрикс, Инк. Составы, содержащие пептиды, ингибирующие мк2
RU2017135072A (ru) * 2015-03-12 2019-04-10 Мори Матрикс, Инк. Применение пептидсодержащих композиций ингибитора mk2 для лечения немелкоклеточного рака легкого
US10295527B2 (en) 2016-03-14 2019-05-21 Bruce Yacyshyn Process and system for predicting responders and non-responders to mesalamine treatment of ulcerative colitis
US11946927B2 (en) 2016-03-14 2024-04-02 Musidora Biotechnology Llc Process and system for identifying individuals having a high risk of inflammatory bowel disease and a method of treatment
CA3074440A1 (en) * 2017-09-01 2019-03-07 Excel Med, Llc Pharmaceutical composition for treating keloid and uses thereof
CN115851946B (zh) * 2022-11-24 2023-09-01 中山大学孙逸仙纪念医院 CaMK I作为治疗靶点在制备胰腺癌治疗药物中的应用

Family Cites Families (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1521000A (en) 1975-06-13 1978-08-09 Syntex Puerto Rico Inc Inhalation device
US4192309A (en) 1978-09-05 1980-03-11 Syntex Puerto Rico, Inc. Inhalation device with capsule opener
US4227522A (en) 1978-09-05 1980-10-14 Syntex Puerto Rico, Inc. Inhalation device
IE56059B1 (en) 1982-10-08 1991-04-10 Glaxo Group Ltd Devices for administering medicaments to patients
US4778054A (en) 1982-10-08 1988-10-18 Glaxo Group Limited Pack for administering medicaments to patients
GR861995B (en) 1985-07-30 1986-11-04 Glaxo Group Ltd Devices for administering medicaments to patients
US5175144A (en) * 1988-11-29 1992-12-29 The Johns Hopkins University Method of retarding the progression of chronic renal failure
JPH05963A (ja) 1990-04-13 1993-01-08 Toray Ind Inc ポリペプチド類組成物
AU654483B2 (en) 1990-04-18 1994-11-10 University Of Utah Research Foundation Crosslinked hydrogels containing azobonds
DE69333955D1 (de) 1992-04-24 2006-02-02 Stanford Res Inst Int Targeting homologer sequenzen in eukaryotenzellen
US6582728B1 (en) 1992-07-08 2003-06-24 Inhale Therapeutic Systems, Inc. Spray drying of macromolecules to produce inhaleable dry powders
ATE196311T1 (de) 1993-12-09 2000-09-15 Univ Jefferson Verbindungen und verfahren zur ortsspezifischen mutation in eukaryotischen zellen
US6221355B1 (en) 1997-12-10 2001-04-24 Washington University Anti-pathogen system and methods of use thereof
US7041814B1 (en) 1998-02-18 2006-05-09 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to Enterobacter cloacae for diagnostics and therapeutics
US7601685B2 (en) 1998-08-27 2009-10-13 Eidgenossische Technische Hochschule Zurich Growth factor modified protein matrices for tissue engineering
US7615373B2 (en) 1999-02-25 2009-11-10 Virginia Commonwealth University Intellectual Property Foundation Electroprocessed collagen and tissue engineering
US20020009491A1 (en) 2000-02-14 2002-01-24 Rothbard Jonathan B. Compositions and methods for enhancing drug delivery across biological membranes and tissues
CA2419379C (en) 2000-08-15 2011-10-11 Surmodics, Inc. Medicament incorporation matrix
EP1351702B1 (en) * 2000-12-08 2015-03-04 Bioprovar Corporation Trem-1 splice variant for use in modifying immune responses
EP1351980B1 (en) 2001-01-18 2014-12-31 The Board Of Trustees Of The Leland Stanford Junior University Peptides for activation and inhibition of delta pkc
DE10118774A1 (de) * 2001-04-17 2002-10-31 Jerini Ag Verfahren zur Bestimmung der Substratspezifität einer enzymatischen Aktivität und Vorrichtung hierzu
US7361352B2 (en) * 2001-08-15 2008-04-22 Acambis, Inc. Influenza immunogen and vaccine
CA2458574A1 (en) 2001-08-23 2003-03-06 Arizona Board Of Regents Reagents and methods for smooth muscle therapies
US20030134810A1 (en) 2001-10-09 2003-07-17 Chris Springate Methods and compositions comprising biocompatible materials useful for the administration of therapeutic agents
WO2003072801A2 (en) 2002-02-21 2003-09-04 The Rockefeller University Compositions and method for regulation of calcium-dependent signalling in brain
US20040005686A1 (en) * 2002-03-07 2004-01-08 Pharmacia Corporation Crystalline structure of human MAPKAP kinase-2
US20070026518A1 (en) 2005-03-29 2007-02-01 The Regents Of The University Of California Controlling stem cell destiny with tunable matrices
AU2003260668A1 (en) 2002-04-01 2003-10-20 Arizona Board Of Regents, A Body Corporate Acting On Behalf Of Arizona State University Biological affinity based delivery systems
US7364870B2 (en) 2002-08-02 2008-04-29 Wyeth MK2 interacting proteins
JP2006514043A (ja) 2002-12-20 2006-04-27 ファルマシア・コーポレーション マイトジェン活性化タンパク質キナーゼ−活性化タンパク質キナーゼ−２を阻害する化合物
ATE332703T1 (de) 2003-02-21 2006-08-15 Univ Arizona Verwendung von hsp20 zur förderung der wundheilung und / oder zur reduzierung von narbenbildung
IL156429A0 (en) 2003-06-12 2004-01-04 Peptor Ltd Cell permeable conjugates of peptides for inhibition of protein kinases
JP2007508823A (ja) 2003-10-17 2007-04-12 アリゾナ ボード オブ リージェンツ 新規な熱ショックタンパク質２０関連ポリペプチドおよびその使用
DE602005013670D1 (de) * 2004-05-21 2009-05-14 Inst Systems Biology Zusammensetzungen und verfahren zur quantifizierung von serumglykoproteinen
WO2006132647A2 (en) 2004-07-23 2006-12-14 The Trustees Of The University Of Pennsylvania Antimicrobial copolymers and uses thereof
US20060115453A1 (en) * 2004-11-12 2006-06-01 Yaffe Michael B Methods and compositions for treating cellular proliferative diseases
EP1824336A4 (en) * 2004-12-02 2009-10-14 Univ North Carolina INHIBITION OF PHOSPHORYLATION HSP27 TO TREAT VESICATION DISORDERS
US7252729B2 (en) 2004-12-29 2007-08-07 Owens-Corning Fiberglas Technology Inc. Polymer/WUCS mat for use in sheet molding compounds
WO2006113667A1 (en) 2005-04-15 2006-10-26 University Of Arizona Therapeutic peptides for the treatment of metastatic cancer
AT502695A1 (de) 2005-10-20 2007-05-15 Voest Alpine Ind Anlagen Verfahren zur herstellung einer strangführungsrolle, eine nach dem verfahren hergestellte strangführungsrolle und deren verwendung
ES2628031T3 (es) 2005-10-26 2017-08-01 Genesis Technologies Limited Matrices de regeneración tisular acelulares bioabsorbibles producidas mediante incubación de productos sanguíneos acelulares
AU2006308989A1 (en) 2005-11-01 2007-05-10 The Arizona Board Of Regents, A Body Corporate Acting On Behalf Of Arizona State University Novel protein transduction domains and uses therefor
US20070154448A1 (en) 2005-11-22 2007-07-05 Ted Reid Methods and compositions using Substance P to promote wound healing
JP5048772B2 (ja) 2006-07-12 2012-10-17 ジ アリゾナ ボード オブ レジェンツ，ア ボディ コーポレイト アクティング フォア アンド オン ビハーフ オブ アリゾナ ステート ユニバーシティ 線維性疾患及びケロイドを治療及び抑制する方法
DK2617431T3 (da) 2007-01-10 2017-07-10 Purdue Research Foundation Polypeptidinhibitorer af HSP27-kinase og anvendelser derfor
US20080293640A1 (en) 2007-01-10 2008-11-27 Arizona Board of Regents, A body Corporate, of the State of Arizona, acting for and on behalf of Polypeptide inhibitors of HSP27 kinase and uses therefor
DK2185698T3 (da) * 2007-08-07 2015-07-27 Purdue Research Foundation Kinaseinhibitorer og anvendelser deraf
WO2009123759A2 (en) 2008-04-02 2009-10-08 Moerae Matrix, Inc. Therapeutic uses of biocompatible biogel compositions
AU2009322865B2 (en) * 2008-10-20 2013-07-18 Moerae Matrix, Inc. Polypeptide for treating or preventing adhesions
KR101965255B1 (ko) * 2008-12-10 2019-04-03 퍼듀 리서치 파운데이션 키나아제의 세포-침투성 펩티드-기초된 저해물질
WO2011017132A2 (en) 2009-07-27 2011-02-10 Purdue Research, Foundation Mk2 inhibitor compositions and methods to enhance neurite outgrowth, neuroprotection, and nerve regeneration
EP2575855A4 (en) * 2010-05-24 2014-03-12 Moerae Matrix Inc METHOD FOR TREATING OR PREVENTING VASCULAR GRAFT BREAKAGE
ES2711670T3 (es) 2011-04-12 2019-05-06 Moerae Matrix Inc Composiciones y métodos para la prevención o tratamiento de la fibrosis pulmonar

Also Published As

Publication number Publication date
CA2898230C (en) 2018-04-24
DK2606903T3 (da) 2016-12-05
US9649354B2 (en) 2017-05-16
US20170072009A1 (en) 2017-03-16
CA2689296A1 (en) 2008-07-17
US20090196927A1 (en) 2009-08-06
EP2606903B1 (en) 2016-09-14
AU2007342674A1 (en) 2008-07-17
EP2617431B1 (en) 2017-04-12
EP2617431A2 (en) 2013-07-24
EP2155228B1 (en) 2014-04-02
CA2689296C (en) 2015-11-17
EP2617431A3 (en) 2013-12-11
EP2155228A4 (en) 2010-06-16
US20140112947A1 (en) 2014-04-24
ES2476842T3 (es) 2014-07-15
US9493508B2 (en) 2016-11-15
US8536303B2 (en) 2013-09-17
AU2007342674B2 (en) 2013-09-19
EP2606903A1 (en) 2013-06-26
ES2624196T3 (es) 2017-07-13
CA2898230A1 (en) 2008-07-17
EP2155228A1 (en) 2010-02-24
ES2594281T3 (es) 2016-12-19
WO2008085191A1 (en) 2008-07-17
DK2617431T3 (da) 2017-07-10

Similar Documents

Publication Publication Date Title
DK2155228T3 (da) Polypeptidinhibitorer af HSP27-kinase og anvendelser herfor
DK2209806T3 (da) Anti-hepcidin-antistoffer og anvendelser deraf
DK2142529T3 (da) Trpv1-antagonister og anvendelser deraf
DK2059535T3 (da) Prlr-specifikt antistof og anvendelser deraf
DK2147096T3 (da) Modificerede faktor-VII-polypeptider og anvendelser deraf
DK2234985T3 (da) 4-(4-cyano-2-thioaryl)-dihydropyrimidinoner og deres anvendelse
DK2068887T3 (da) SP35-antistoffer og anvendelser heraf
DK2118140T3 (da) Humancytomegalovirus-neutraliserende antistoffer og anvendelse deraf
DK2124999T3 (da) Activin-actrii antagonister og anvendelser til behandling af anæmi
DK2157967T3 (da) Suspensionsformuleringer af insulinotropiske peptider og anvendelser deraf
DK2170287T3 (da) Mikropartikler omfattende PCL og anvendelser deraf
DK2222675T3 (da) 5-anilinoimidazopyridiner og fremgangsmåder til deres anvendelse
DK2173378T3 (da) Komplekser af il-15 og il-15ralfa og anvendelser deraf
DK2120604T3 (da) Fremgangsmåde til fraktionering af havre, produkter derved opnået, og anvendelser deraf
DK1846445T3 (da) PYY-agonister og anvendelser deraf
DK2913344T3 (da) Specifikke bindingsproteiner og anvendelser deraf
DK3124497T3 (da) Rationelt designede syntetiske antistofbiblioteker og anvendelser deraf
DK2170827T3 (da) Indolin-2-oner og aza-indolin-2-oner
DK2012773T3 (da) Lægemidler og anvendelser deraf
DK1994055T3 (da) Anti-5t4-antistoffer og anvendelser deraf
DK2470656T3 (da) Sammensætning til hæmning af genekspression og anvendelser heraf
DK2188264T3 (da) Pyridazinonforbindelse og herbicid indeholdende det samme
BRPI0719369A2 (pt) Porta-prótese e aplicações do mesmo
DK2079485T3 (da) Phenylpropionamidforbindelser og anvendelsen deraf
DK1997081T3 (da) Indretning og fremgangsmåde til opbevaring og udlevering af pengesedler